Optimizing Care in Perioperative Immunotherapy for G/GEJ Adenocarcinoma.
Please visit www.answersincme.com/102331945860 to participate, download slides and supporting materials, complete the post-test, and get a certificate. Presented by Elizabeth Smyth, MD, FRCP, and Daniela Molena, MD. In this activity, experts in gastric/gastroesophageal junction adenocarcinoma discuss the latest evidence and practical strategies for optimizing the treatment of resectable gastric (G)/gastroesophageal junction (GEJ) adenocarcinoma with perioperative immunotherapy. Upon completion of this activity, participants should be better able to: Evaluate the evidence supporting the integration of perioperative immunotherapy (IO) in the treatment of resectable gastric (G)/gastroesophageal junction (GEJ) adenocarcinoma. Analyze the role of biomarkers in decision-making for perioperative IO in resectable G/GEJ adenocarcinoma. Outline multidisciplinary strategies for optimizing the care of patients receiving perioperative IO for resectable G/GEJ adenocarcinoma.
Strategic Sequencing: Mapping the Optimal Path for Later-Line mCRC Care
The Next Chapter in ILD Care: Integrating Emerging Data on Novel Antifibrotics Into Practice
Transforming Outcomes for Patients With Chronic Spontaneous Urticaria: New Era of Targeted Therapy
A Collaborative Discussion on CSCC Neoadjuvant and Adjuvant Immunotherapy
From Evidence to Impact: Leveraging the Latest Data to Elevate Standards and Outcomes in mHSPC
TypeScript in Express – TypeScript Tutorial
This Bassett Hound WAS Trying to Tell me Something…He Was Right | PUPDATE
Chichvarkin Saves Putin | Vitaly Portnikov
Making a Diagnosis of PSP, CBD, or MSA
Evoque Tricuspid Intervention:Jubin Joseph, MD
Inflation, Deficits, Interest Rates: Warning, Immediate Danger!
Why does every mammal get 1 billion heartbeats in their life?
12 Warning Signs Your Body Is Aging Faster Than It Should
Starship #13 ist nicht explodiert? | SPACE NEWS
Ovarian Cancer & Gastrointestinal Issues
ESR1m Testing + Novel Oral SERDS In Multidisciplinary Workflows for HR+/HER2− aBC:NE/Mid-Atlantic US
The One Consistency Principle Top Performers Never Skip | Jon Gordon
The Immunotherapy Casebook: Practical Approaches in Frontline Metastatic NSCLC Treatment
Translating Evidence Into Practice: Optimizing Chemotherapy-Free Intervals and Sequencing in mCRC
